$DCPH

02.12.20 Secondary Announcement

This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]

08.13.19 Secondary Announcement

This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]

Deciphera Pharmaceuticals (DCPH) IPO Preview

Company: Deciphera Pharmaceuticals Symbol: DCPH Description: They are a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of many cancer therapies. Shares: 6.25 million Price Range: $15.00-$17.00 Trade Date: 9/28 Underwriter(s): J.P. Morgan, Piper Jaffray[…]

Scroll to top
error: Content is protected !!